Drug company Indies Pharma Jamaica Limited is looking to double next year’s revenues, following approval of its abbreviated new drug application,...
Vous n'êtes pas connecté
Ahmedabad, India, 19 July 2024 Zydus Lifesciences Limited (including its subsidiaries/ affiliates, hereafter referred to as “Zydus”) has received final approval for its New Drug Application (NDA) from the United States Food and Drug...
Drug company Indies Pharma Jamaica Limited is looking to double next year’s revenues, following approval of its abbreviated new drug application,...
Updated Date: Wed, 04 Sep 2024 00:00:00 EDT
Updated Date: Wed, 04 Sep 2024 00:00:00 EDT
Indoco Remedies Limited (Indoco) announced the receipt of final approval from the US FDA for Abbreviated New Drug Application (ANDA) for lofexidine...
Indoco Remedies Limited (Indoco) announced the receipt of final approval from the US FDA for Abbreviated New Drug Application (ANDA) for lofexidine...
CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)--Sep. 3, 2024-- KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), today announced that the U.S....
Khaitan & Co. advised Zydus Lifesciences Limited (Zydus) on the deal. Zydus Lifesciences Limited (Zydus) secured the acquisition of 50% equity...
Khaitan & Co. advised Zydus Lifesciences Limited (Zydus) on the deal. Zydus Lifesciences Limited (Zydus) secured the acquisition of 50% equity...
KalVista announces FDA acceptance of New Drug Application for sebetralstat for oral on-demand treatment of hereditary angioedema KalVista...
The FDA approves subcutaneous formulation of RHHBY's leading immunotherapy drug, Tecentriq, under the brand name Tecentriq Hybreza.